Literature DB >> 19569130

Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.

Cristina Sanchez-Castaneda1, Ramon Rene, Blanca Ramirez-Ruiz, Jaume Campdelacreu, Jordi Gascon, Carles Falcon, Matilde Calopa, Serge Jauma, Montserrat Juncadella, Carme Junque.   

Abstract

There is controversy regarding whether Dementia with Lewy Bodies (DLB) and Parkinson's disease with dementia (PDD) may or not be different manifestations of the same disorder. The purpose of the present study was to investigate possible correlations between brain structure and neuropsychological functions in clinically diagnosed patients with DLB and PDD. The study sample consisted of 12 consecutively referred DLB patients, 16 PDD patients, and 16 healthy control subjects recruited from an outpatient setting, who underwent MRI and neuropsychological assessment. Voxel-based morphometry results showed that DLB patients had greater gray matter atrophy in the right superior frontal gyrus, the right premotor area and the right inferior frontal lobe compared to PDD. Furthermore, the anterior cingulate and prefrontal volume correlated with performance on the Continuous Performance Test while the right hippocampus and amygdala volume correlated with Visual Memory Test in the DLB group. In conclusion, DLB patients had more fronto-temporal gray matter atrophy than PDD patients and these reductions correlated with neuropsychological impairment.

Entities:  

Mesh:

Year:  2009        PMID: 19569130     DOI: 10.1002/mds.22488

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

Review 1.  Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.

Authors:  Ping Lei Pan; Hai Cun Shi; Jian Guo Zhong; Pei Rong Xiao; Yuan Shen; Li Juan Wu; Yuan Ying Song; Gui Xiang He; Hua Liang Li
Journal:  Neurol Sci       Date:  2012-11-27       Impact factor: 3.307

Review 2.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

4.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Authors:  Daniel Weintraub; Nicole Dietz; John E Duda; David A Wolk; Jimit Doshi; Sharon X Xie; Christos Davatzikos; Christopher M Clark; Andrew Siderowf
Journal:  Brain       Date:  2011-11-21       Impact factor: 13.501

Review 5.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

6.  Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson's disease.

Authors:  Tomoko Maekawa; Noriko Sato; Miho Ota; Atsuhiko Sugiyama; Daichi Sone; Mikako Enokizono; Yukio Kimura; Youhei Mukai; Miho Murata; Harumasa Takano; Etsuko Imabayashi; Hiroshi Matsuda; Akira Kunimatsu; Osamu Abe
Journal:  Jpn J Radiol       Date:  2017-10-23       Impact factor: 2.374

Review 7.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

8.  Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.

Authors:  Yaqian Xu; Jing Yang; Xinyu Hu; Huifang Shang
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

9.  Voxelwise meta-analysis of gray matter anomalies in progressive supranuclear palsy and Parkinson's disease using anatomic likelihood estimation.

Authors:  Na Shao; Jing Yang; Jianpeng Li; Hui-Fang Shang
Journal:  Front Hum Neurosci       Date:  2014-02-18       Impact factor: 3.169

Review 10.  Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.

Authors:  N W Sterling; M M Lewis; G Du; X Huang
Journal:  J Parkinsons Dis       Date:  2016-05-27       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.